The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

The motor neuron disease treatment market is witnessing substantial growth, primarily fueled by the rising incidence of conditions like Amyotrophic L ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

Researchers in Shanghai have made a major clinical-stage breakthrough in brain-computer interfaces (BCI) researches by ...

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

The former bassist of Canadian punk band Comeback Kid was diagnosed with a neurodegenerative disease last year ...

Motor neurone disease (MND) is a rare but progressive neurological disorder characterised by the degeneration of motor ...

Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...